• Consensus Rating: Hold
  • Consensus Price Target: $54.17
  • Forecasted Upside: 21.04%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$44.75
▲ +0.53 (1.20%)

This chart shows the closing price for NGVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ingevity Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NGVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NGVT

Analyst Price Target is $54.17
▲ +21.04% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Ingevity in the last 3 months. The average price target is $54.17, with a high forecast of $62.00 and a low forecast of $45.00. The average price target represents a 21.04% upside from the last price of $44.75.

This chart shows the closing price for NGVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Ingevity. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/16/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/15/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/11/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$55.00 ➝ $45.00Low
5/8/2024BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$50.00 ➝ $55.00Low
5/7/2024Loop CapitalBoost TargetHold ➝ Hold$49.00 ➝ $56.00Low
5/2/2024OppenheimerBoost TargetOutperform ➝ Outperform$50.00 ➝ $58.00Low
4/22/2024Jefferies Financial GroupUpgradeHold ➝ Buy$52.00 ➝ $62.00Low
2/23/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$43.00 ➝ $50.00Low
11/9/2023BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$54.00 ➝ $43.00Low
11/6/2023CJS SecuritiesDowngradeOutperform ➝ Market Perform$49.00Low
10/3/2023Loop CapitalDowngradeBuy ➝ Hold$62.00 ➝ $53.00Low
8/7/2023BMO Capital MarketsDowngradeOutperform ➝ Market Perform$71.00 ➝ $60.00Low
7/27/2023Loop CapitalUpgradeHold ➝ Buy$64.00 ➝ $75.00Low
5/23/2023Wells Fargo & CompanyLower Target$66.00 ➝ $55.00Low
5/9/2023BMO Capital MarketsLower Target$100.00 ➝ $80.00Low
5/5/2023Loop CapitalDowngradeBuy ➝ Hold$92.00 ➝ $64.00Low
4/17/2023Wells Fargo & CompanyLower TargetEqual Weight$85.00 ➝ $80.00Low
3/24/2023Loop CapitalLower TargetBuy$100.00 ➝ $92.00Low
3/1/2023Wells Fargo & CompanyBoost TargetEqual Weight$76.00 ➝ $85.00Low
2/2/2023Loop CapitalUpgradeHold ➝ Buy$81.00 ➝ $100.00Low
1/9/2023Wells Fargo & CompanyBoost TargetEqual Weight$73.00 ➝ $76.00Low
11/4/2022Wells Fargo & CompanyBoost TargetEqual Weight$67.00 ➝ $73.00Low
10/18/2022Wells Fargo & CompanyLower TargetEqual Weight$74.00 ➝ $67.00Low
10/11/2022BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$89.00 ➝ $87.00Low
11/18/2021Loop CapitalLower TargetHold$92.00 ➝ $81.00Low
10/29/2021Wells Fargo & CompanyBoost TargetEqual Weight$82.00 ➝ $84.00Low
7/29/2021OppenheimerBoost TargetOutperform$85.00 ➝ $95.00High
7/9/2021BMO Capital MarketsReiterated RatingBuy$112.00Low
5/27/2021Loop CapitalBoost TargetHold$71.00 ➝ $85.00Low
5/4/2021BMO Capital MarketsBoost TargetOutperform$100.00 ➝ $110.00Low
2/11/2021OppenheimerBoost TargetOutperform$75.00 ➝ $85.00Low
2/8/2021Loop CapitalDowngradeBuy ➝ HoldHigh
10/22/2020BMO Capital MarketsBoost TargetPositive ➝ Outperform$86.00 ➝ $90.00High
8/11/2020Jefferies Financial GroupReiterated RatingHold$58.00High
8/6/2020BMO Capital MarketsBoost TargetOutperform$79.00 ➝ $84.00Low
7/31/2020Stifel NicolausUpgradeHold ➝ Buy$55.00 ➝ $66.00High
5/6/2020OppenheimerReiterated RatingBuy$65.00Low
5/1/2020Wells Fargo & CompanyBoost TargetEqual Weight$43.00 ➝ $55.00Medium
4/30/2020OppenheimerLower TargetOutperform$80.00 ➝ $65.00High
4/20/2020BMO Capital MarketsLower TargetOutperform$111.00 ➝ $74.00Low
4/3/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$43.00High
3/24/2020SunTrust BanksLower Target$112.00 ➝ $75.00Low
3/24/2020Stifel NicolausLower TargetHold$67.00 ➝ $42.00Medium
2/21/2020Stifel NicolausLower TargetHold$76.00 ➝ $67.00High
2/5/2020BMO Capital MarketsReiterated RatingOutperform$111.00Medium
2/4/2020Wells Fargo & CompanyLower TargetOverweight$100.00 ➝ $83.00Medium
1/24/2020Loop CapitalUpgradeHold ➝ Buy$94.00Medium
12/6/2019Loop CapitalDowngradeBuy ➝ Hold$96.00Low
10/28/2019BMO Capital MarketsLower TargetOutperform$121.00High
10/25/2019SunTrust BanksLower TargetBuy$120.00Low
10/15/2019Wells Fargo & CompanyInitiated CoverageOutperform$100.00Low
9/27/2019BMO Capital MarketsLower TargetOutperform$131.00 ➝ $127.00Medium
9/25/2019Stifel NicolausLower TargetHold$109.00 ➝ $99.00Medium
9/5/2019Loop CapitalUpgradeHold ➝ BuyHigh
7/19/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$129.00 ➝ $107.00Low
7/18/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$101.29Medium
(Data available from 7/15/2019 forward)

News Sentiment Rating

1.21 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 9 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/16/2024
  • 12 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/17/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/16/2024
  • 7 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/16/2024
  • 8 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/15/2024
  • 7 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 7 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Ingevity logo
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Read More

Today's Range

Now: $44.75
Low: $44.17
High: $45.57

50 Day Range

MA: $47.29
Low: $40.62
High: $55.12

52 Week Range

Now: $44.75
Low: $36.66
High: $66.18

Volume

143,551 shs

Average Volume

230,571 shs

Market Capitalization

$1.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Ingevity?

The following Wall Street analysts have issued research reports on Ingevity in the last year: BMO Capital Markets, CJS Securities, Jefferies Financial Group Inc., Loop Capital, Oppenheimer Holdings Inc., StockNews.com, and Wells Fargo & Company.
View the latest analyst ratings for NGVT.

What is the current price target for Ingevity?

6 Wall Street analysts have set twelve-month price targets for Ingevity in the last year. Their average twelve-month price target is $54.17, suggesting a possible upside of 22.5%. Jefferies Financial Group Inc. has the highest price target set, predicting NGVT will reach $62.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $45.00 for Ingevity in the next year.
View the latest price targets for NGVT.

What is the current consensus analyst rating for Ingevity?

Ingevity currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NGVT, but not buy more shares or sell existing shares.
View the latest ratings for NGVT.

What other companies compete with Ingevity?

Other companies that are similar to Ingevity include Olin, Balchem, Ashland, Huntsman and Chemours. Learn More about companies similar to Ingevity.

How do I contact Ingevity's investor relations team?

Ingevity's physical mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The company's listed phone number is (843) 740-2300 and its investor relations email address is [email protected]. The official website for Ingevity is www.ingevity.com. Learn More about contacing Ingevity investor relations.